Should Central Serous Chorioretinopathy Be Added to the List of Ocular Side Effects of Phosphodiesterase 5 Inhibitors?

Publisher: Karger

E-ISSN: 1423-0267|227|2|85-89

ISSN: 0030-3755

Source: Ophthalmologica, Vol.227, Iss.2, 2011-12, pp. : 85-89

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract